NeuroVanda Therapeutics
- Biotech or pharma, therapeutic R&D
NeuroVanda is a Singapore-based biotech startup focused on developing transformational therapies for neurodegenerative diseases. Our team comprises experienced drug hunters as well as world-renowned experts and pioneers in the field of neurodegenerative diseases (Prof. Virginia Lee from University of Pennsylvania, Prof. Li Gan from Weill Cornell Medicine, and Prof Adam Boxer from UCSF). NeuroVanda is leveraging translational models developed in the labs of our scientific founders and are guided by their profound insights in the field to further establish pathophysiologically relevant models. The NeuroVanda team is also experienced in developing novel modalities such as small molecule protein degraders to tackle the most pertinent of disease targets.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}